240 related articles for article (PubMed ID: 21124329)
21. Temporal characteristics of cardiomyocyte hypertrophy in the spontaneously hypertensive rat.
Bell D; Kelso EJ; Argent CC; Lee GR; Allen AR; McDermott BJ
Cardiovasc Pathol; 2004; 13(2):71-8. PubMed ID: 15033155
[TBL] [Abstract][Full Text] [Related]
22. Simvastatin reduces human atrial myofibroblast proliferation independently of cholesterol lowering via inhibition of RhoA.
Porter KE; Turner NA; O'Regan DJ; Balmforth AJ; Ball SG
Cardiovasc Res; 2004 Mar; 61(4):745-55. PubMed ID: 14985071
[TBL] [Abstract][Full Text] [Related]
23. Renin-angiotensin inhibition reverses advanced cardiac remodeling in aging spontaneously hypertensive rats.
Ito N; Ohishi M; Yamamoto K; Tatara Y; Shiota A; Hayashi N; Komai N; Yanagitani Y; Rakugi H; Ogihara T
Am J Hypertens; 2007 Jul; 20(7):792-9. PubMed ID: 17586415
[TBL] [Abstract][Full Text] [Related]
24. [Effects of simvastatin on the left ventricular hypertrophy in spontaneously hypertensive rats and its relationship with the expression of protein kinase B].
Zhao LY; Chen YQ; Zheng QS; Xue YS; Shang FJ; Li AG; Wang B
Zhonghua Yi Xue Za Zhi; 2005 May; 85(19):1344-7. PubMed ID: 16029635
[TBL] [Abstract][Full Text] [Related]
25. Lipoic acid supplementation prevents cyclosporine-induced hypertension and nephrotoxicity in spontaneously hypertensive rats.
Louhelainen M; Merasto S; Finckenberg P; Lapatto R; Cheng ZJ; Mervaala EM
J Hypertens; 2006 May; 24(5):947-56. PubMed ID: 16612258
[TBL] [Abstract][Full Text] [Related]
26. Simvastatin prevents ERK activation in myocardial hypertrophy of spontaneously hypertensive rats.
Huang C; Liu Z; Wang Z; Shen Z; Zhu J
Scand Cardiovasc J; 2010 Dec; 44(6):346-51. PubMed ID: 21080865
[TBL] [Abstract][Full Text] [Related]
27. Rosuvastatin, but not simvastatin, provides end-organ protection in stroke-prone rats by antiinflammatory effects.
Sironi L; Gianazza E; Gelosa P; Guerrini U; Nobili E; Gianella A; Cremonesi B; Paoletti R; Tremoli E
Arterioscler Thromb Vasc Biol; 2005 Mar; 25(3):598-603. PubMed ID: 15681303
[TBL] [Abstract][Full Text] [Related]
28. Statins initiated after hypertrophy inhibit oxidative stress and prevent heart failure in rats with aortic stenosis.
Chen MS; Xu FP; Wang YZ; Zhang GP; Yi Q; Zhang HQ; Luo JD
J Mol Cell Cardiol; 2004 Oct; 37(4):889-96. PubMed ID: 15380679
[TBL] [Abstract][Full Text] [Related]
29. Effects of glitazones on blood pressure and vascular structure in mesenteric resistance arteries and basilar artery from genetically hypertensive rats.
Ledingham JM; Laverty R
Clin Exp Pharmacol Physiol; 2005 Nov; 32(11):919-25. PubMed ID: 16405447
[TBL] [Abstract][Full Text] [Related]
30. PARP inhibition delays transition of hypertensive cardiopathy to heart failure in spontaneously hypertensive rats.
Bartha E; Solti I; Kereskai L; Lantos J; Plozer E; Magyar K; Szabados E; Kálai T; Hideg K; Halmosi R; Sumegi B; Toth K
Cardiovasc Res; 2009 Aug; 83(3):501-10. PubMed ID: 19443425
[TBL] [Abstract][Full Text] [Related]
31. Beneficial effect of atorvastatin on left ventricular remodeling in spontaneously hypertensive rats.
Kang L; Ge CJ; Hu SJ
Pharmacology; 2007; 80(2-3):120-6. PubMed ID: 17534121
[TBL] [Abstract][Full Text] [Related]
32. Chronic inhibition of chemokine receptor CXCR2 attenuates cardiac remodeling and dysfunction in spontaneously hypertensive rats.
Zhang YL; Geng C; Yang J; Fang J; Yan X; Li PB; Zou LX; Chen C; Guo SB; Li HH; Liu Y
Biochim Biophys Acta Mol Basis Dis; 2019 Dec; 1865(12):165551. PubMed ID: 31494226
[TBL] [Abstract][Full Text] [Related]
33. Atorvastatin Attenuates Myocardial Hypertrophy in Spontaneously Hypertensive Rats via the C/EBPβ/PGC-1α/UCP3 Pathway.
Chen Y; Chang Y; Zhang N; Guo X; Sun G; Sun Y
Cell Physiol Biochem; 2018; 46(3):1009-1018. PubMed ID: 29669326
[TBL] [Abstract][Full Text] [Related]
34. Mechanisms of blood pressure variability-induced cardiac hypertrophy and dysfunction in mice with impaired baroreflex.
Martinka P; Fielitz J; Patzak A; Regitz-Zagrosek V; Persson PB; Stauss HM
Am J Physiol Regul Integr Comp Physiol; 2005 Mar; 288(3):R767-76. PubMed ID: 15563577
[TBL] [Abstract][Full Text] [Related]
35. Qingda granules attenuate hypertensive cardiac remodeling and inflammation in spontaneously hypertensive rats.
Wu X; Shen A; Bao L; Wu M; Lin X; Wang H; Chen Y; Cai Q; Lin S; Zhou X; Lu Y; Peng M; Chen D; Chu J; Peng J
Biomed Pharmacother; 2020 Sep; 129():110367. PubMed ID: 32559624
[TBL] [Abstract][Full Text] [Related]
36. [Simvastatin inhibits hypertension-induced cardiac hypertrophy in rats through activation of heme oxygenase-1/carbon monoxide pathway].
Yao HM; Wu XS; Zhang J; Geng B; Tang CS
Sheng Li Xue Bao; 2006 Apr; 58(2):116-23. PubMed ID: 16628357
[TBL] [Abstract][Full Text] [Related]
37. Simvastatin induces a central hypotensive effect via Ras-mediated signalling to cause eNOS up-regulation.
Cheng WH; Ho WY; Chang CF; Lu PJ; Cheng PW; Yeh TC; Hong LZ; Sun GC; Hsiao M; Tseng CJ
Br J Pharmacol; 2013 Oct; 170(4):847-58. PubMed ID: 23889671
[TBL] [Abstract][Full Text] [Related]
38. [Blood pressure variability-induced aggravation of hypertensive organ damages].
Kai H
Nihon Rinsho; 2015 Nov; 73(11):1939-45. PubMed ID: 26619672
[TBL] [Abstract][Full Text] [Related]
39. Epigenetic Therapy for the Treatment of Hypertension-Induced Cardiac Hypertrophy and Fibrosis.
Watson CJ; Horgan S; Neary R; Glezeva N; Tea I; Corrigan N; McDonald K; Ledwidge M; Baugh J
J Cardiovasc Pharmacol Ther; 2016 Jan; 21(1):127-37. PubMed ID: 26130616
[TBL] [Abstract][Full Text] [Related]
40. Simvastatin induces regression of cardiac hypertrophy and fibrosis and improves cardiac function in a transgenic rabbit model of human hypertrophic cardiomyopathy.
Patel R; Nagueh SF; Tsybouleva N; Abdellatif M; Lutucuta S; Kopelen HA; Quinones MA; Zoghbi WA; Entman ML; Roberts R; Marian AJ
Circulation; 2001 Jul; 104(3):317-24. PubMed ID: 11457751
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
